These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15729131)

  • 1. Candesartan reduces superoxide production after global cerebral ischemia.
    Sugawara T; Kinouchi H; Oda M; Shoji H; Omae T; Mizoi K
    Neuroreport; 2005 Mar; 16(4):325-8. PubMed ID: 15729131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
    Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
    J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
    Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
    J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
    Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
    Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of Neuroprotection by a Combination of the Biological Antioxidant (
    Trabolsi C; Takash Chamoun W; Hijazi A; Nicoletti C; Maresca M; Nasser M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats.
    Kim-Mitsuyama S; Yamamoto E; Tanaka T; Zhan Y; Izumi Y; Izumiya Y; Ioroi T; Wanibuchi H; Iwao H
    Stroke; 2005 May; 36(5):1083-8. PubMed ID: 15817892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
    Engelhorn T; Goerike S; Doerfler A; Okorn C; Forsting M; Heusch G; Schulz R
    J Cereb Blood Flow Metab; 2004 Apr; 24(4):467-74. PubMed ID: 15087716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.
    Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K
    Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
    Wang QD; Sjöquist PO
    Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury.
    Kusaka I; Kusaka G; Zhou C; Ishikawa M; Nanda A; Granger DN; Zhang JH; Tang J
    Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2442-51. PubMed ID: 15148062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiotensin II AT1-receptor antagonist candesartan improves functional recovery and reduces the no-reflow area in reperfused ischemic rat hearts.
    Shimizu M; Wang QD; Sjöquist PO; Rydén L
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):78-81. PubMed ID: 10413071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
    Yang H; Hirooka K; Fukuda K; Shiraga F
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5800-4. PubMed ID: 19608537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
    Krikov M; Thone-Reineke C; Müller S; Villringer A; Unger T
    J Hypertens; 2008 Mar; 26(3):544-52. PubMed ID: 18300867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT1 receptor blocker candesartan-induced attenuation of brain injury of rats subjected to chronic cerebral hypoperfusion.
    Ozacmak VH; Sayan H; Cetin A; Akyildiz-Igdem A
    Neurochem Res; 2007 Aug; 32(8):1314-21. PubMed ID: 17401654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage.
    Villapol S; Balarezo MG; Affram K; Saavedra JM; Symes AJ
    Brain; 2015 Nov; 138(Pt 11):3299-315. PubMed ID: 26115674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke.
    Fouda AY; Alhusban A; Ishrat T; Pillai B; Eldahshan W; Waller JL; Ergul A; Fagan SC
    Mol Neurobiol; 2017 Jan; 54(1):661-670. PubMed ID: 26758277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke.
    Kobayashi T; Kawamata T; Shibata N; Okada Y; Kobayashi M; Hori T
    J Neurotrauma; 2009 Dec; 26(12):2355-64. PubMed ID: 19604102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.